about
From molecular phylogeny towards differentiating pharmacology for NMDA receptor subtypesIn the picture: disulfide-poor conopeptides, a class of pharmacologically interesting compoundsGlutamate receptor ion channels: structure, regulation, and functionLigands for ionotropic glutamate receptorsCharacterization of conantokin Rl-A: molecular phylogeny as structure/function study.Conantokins derived from the Asprella clade impart conRl-B, an N-methyl d-aspartate receptor antagonist with a unique selectivity profile for NR2B subunits.A novel approach for in vivo screening of toxins using the Drosophila Giant Fiber circuit.Effect of Conantokin G on NMDA receptor-mediated spontaneous EPSCs in cultured cortical neurons.Novel conantokins from Conus parius venom are specific antagonists of N-methyl-D-aspartate receptors.Conantokin-Br from Conus brettinghami and selectivity determinants for the NR2D subunit of the NMDA receptor.Stapling mimics noncovalent interactions of γ-carboxyglutamates in conantokins, peptidic antagonists of N-methyl-D-aspartic acid receptorsPaired nanoinjection and electrophysiology assay to screen for bioactivity of compounds using the Drosophila melanogaster giant fiber systemClassifying neuronal subclasses of the cerebellum through constellation pharmacology.Neuroprotective and cardioprotective conopeptides: an emerging class of drug leads.Recent progress in neuroactive marine natural products.Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain.Conotoxins: Therapeutic Potential and Application.
P2860
Q27681642-039E6720-B9C5-4B39-B8C7-C18070C0E954Q28066688-7F5192B9-1C6E-4292-953D-A93B66CECABCQ28290774-CA2A2747-7126-4C45-AD73-1278D1515140Q33980883-CB55FB2D-30F3-4AFB-9B1B-DCF4EE3B4063Q34062213-A16730B2-49BA-4542-A8C3-755EBF7343E2Q34129177-8A39867D-A192-4FC8-9512-1577DACD73E1Q34258891-E7FC076A-F1C8-4B7E-8F68-06946847CD4FQ34535794-1EF78061-2A4A-4BCB-B11D-9DDBEB634B46Q34706882-709E0C26-0AFD-416A-8338-14B41AFB4EDBQ34967718-76981290-A1B4-4498-9EA0-6E2A66591685Q36017011-CF077E55-65A9-4E8A-91B3-8118DA39F4C4Q36304469-2734B4F5-240A-40C9-A002-11E75A3D621AQ36956308-8B82184D-8947-48B3-96E3-7C124F5B8A5AQ37427566-1B502B9A-8EAA-4225-A6EF-73E55392D085Q37639029-3A4C753E-3C6F-4394-9D07-B4C56B2DCFB9Q41835834-2CCFA215-31B2-4F6E-AF53-DB460901E760Q46364124-5480B7F4-38DF-4F3B-A247-CF2D09ED8E85
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Conantokins: peptide antagonists of NMDA receptors.
@ast
Conantokins: peptide antagonists of NMDA receptors.
@en
type
label
Conantokins: peptide antagonists of NMDA receptors.
@ast
Conantokins: peptide antagonists of NMDA receptors.
@en
prefLabel
Conantokins: peptide antagonists of NMDA receptors.
@ast
Conantokins: peptide antagonists of NMDA receptors.
@en
P2093
P356
P1476
Conantokins: peptide antagonists of NMDA receptors.
@en
P2093
H Steve White
John D Wagstaff
Richard T Layer
P304
P356
10.2174/0929867043363901
P577
2004-12-01T00:00:00Z